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Executive Summary
Post-cardiac arrest is a critical time for both the patients and those involved in their
treatment. Many factors can contribute to a patient experiencing cardiac arrest, such as a history
of arrythmias, septic shock and various comorbidities. Guidelines can change rapidly, and the
efficacy of treatments can be difficult to ascertain due to the inability to separate the effects of
the multitude of intra-code and post-code interventions. However, as resuscitation science
gathers more data, the medical community must adapt to the new information and implement
those changes that have been shown to be beneficial while discontinuing treatments that have no
proven effect. In post-cardiac arrest patients, maintaining a normal body temperature or treating
fever has been shown to be more beneficial than implementing therapeutic hypothermia in
preserving neurological function and reducing mortality.
Following the 2015 American Heart Association guidelines post cardiac arrest, many
hospitals have spent large amounts of money and time to acquire the equipment and train the
staff in the performance of post-arrest targeted temperature management. Targeted temperature
management, or therapeutic hypothermia is performed in order to improve neurological
outcomes for the patient. However, despite this intervention, many patients though successfully
resuscitated from cardiac arrest, either die during or shortly after the hospital stay or are
persistently neurologically disabled. Many others suffer hospital acquired infections. Subsequent
to the recommendation of the AHA to use TH post resuscitation, more data has been gathered
and analyzed which supports normothermia in place of cooling.
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Therapeutic Hypothermia Benchmark Study
1.

Rationale for the Project

Currently, in this organization, there is no systematic method for examining outcomes in
patients who undergo therapeutic hypothermia or who are managed without TH post-ROSC.
Because this is a smaller Intensive Care Unit, with only 24 beds, and the process of cooling and
rewarming takes several days, most nurses are aware of when a TH patient is admitted and what
the outcome after rewarming is, however, no formal process exists to determine if this
intervention results in any noticeable benefit to the patients. This year, only 2 patients have
undergone TH. Both showed significant neurological deficits several days after rewarming and
the families elected to withdraw care.
Families show significant distress while waiting for the patient to go through TH and
rewarming with the hopes of waking up. These patients and families are experiencing a very
vulnerable and chaotic event with an uncertain outcome. The vulnerability of this patient
population and the risks that are already faced of poor neurological outcome as well as the
continued risk of death suggests that we should not expose them to greater potential for harm.
Therefore, to preserve both life and functionality of this population, providers must
continually receive the latest evidence-based education on interventions showing the greatest
benefit and lowest risk to the patient. In post cardiac arrest patients (P), what is the effect of
therapeutic hypothermia (I) compared to maintaining normal body temperature (C) on patient
neurologic outcomes and mortality (O) over 90 days post arrest (T)?
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2. Literature Synthesis
Cardiac arrest is often a multifactorial problem, originating from an individual’s underlying
comorbidities and aggravated by additional circumstances to culminate in an event. To
standardize resuscitation attempts, the American Heart Association creates and routinely updates
algorithms to maximize the potential for return of spontaneous circulation or ROSC. The AHA
recommends the use of Targeted Temperature Management, or Therapeutic Hypothermia, TH,
for patients that remain comatose post-ROSC (Eken, 2015). Despite this, few survive cardiac
arrest and even when ROSC is achieved, the individual is vulnerable to poor neurological
outcome and has a continued risk of morbidity.
Initial studies that may have prompted these guidelines had small study sizes. Thus,
when larger populations were studied, hypothermia showed no benefit over normothermia for
survival to hospital discharge or neurological outcomes (Eken, 2015). Both TH and Mild
Therapeutic Hypothermia, MTH, have been compared to determine efficacy and shown that
neither produced improved outcomes. However, the management of the patient’s core
temperature to prevent hyperthermia remains a strong recommendation (Ramakrishna et al.,
2016). Survival to hospital discharge is improved when strict normothermia is utilized
(Casamento et al., 2016) (Chan, Berg, Tang, Curtis & Spertus, 2016). The possibility exists that
with the advances in resuscitation science the effectiveness of TH as a post cardiac arrest
intervention was initially overstated due to the inability to fully separate factors of the
resuscitation attempt or post arrest care (Temperikidis & Manolis, 2015).
Due to the variety of reasons that cardiac arrest can occur and the differing patient
populations that experience it from pediatrics to the elderly, several factors have been
independently studied to determine if patients benefited from cooling. Shock is one potential
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cause of cardiac arrest where TTM conveys no benefit (Annborn et al., 2014). Expert review of
evidence states that patients in cardiogenic shock should not be cooled and those in septic shock
should only have hyperthermia treated (Cariou, 2017). Individual case study reports have shown
that TH can lead to QT prolongation in patients with no prior history of arrhythmias and
highlights the potential for fatal arrhythmias (Moeller & Webber, 2017). Furthermore,
implementing TH in the post arrest plan of care is shown to increase the risk of pneumonia and
other hospital acquired infections (Bhattacharjee, Baidya & Maitra, 2015) (Hakim, Ammar &
Reyad, 2018).
Pediatrics and geriatrics must be examined apart from the adult population. Both groups
have differences in organ function and often have several comorbidities that lead to cardiac
arrest. In the pediatric population, no benefit exists in functionality or survival to one year
(Moler et al., 2017). When examining the elderly, age was found to be a predictor of poor
neurological outcomes, in that, for every 10 years younger, the patient was more likely to retain
good function independent of cooling (Oh et al., 2017). Therefore, TH failed to prove a benefit in
the elderly population. The individual examination of these factors as well as different attributes
of the critically ill population post-ROSC, demonstrate that TH is not supported by the evidence
as an intervention post-ROSC.

3. Project Stakeholders
Because this is a corporate hospital, there are immediate stakeholders at the facility who
bring issues to the corporate stakeholders. Some of these stakeholders include the ER medical
director, ICU medical director and the physicians who practice in these areas. Additional
stakeholders include the nursing staff, facility education department, unit educators and unit
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directors. Once the policy change to normothermia passed the immediate stakeholders, it could
be sent as a policy change to corporate. This facility has been chosen to lead several initiatives,
such as the creation of an in-house dialysis team to support the facilities’ needs: therefore,
trialing an initiative in within the facility’s purview.
Broadly, the American Heart Association is affected by withdrawing TH in favor of
normothermia. Not following a guideline of the AHA could be seen as a rejection of their
guidelines for resuscitation. Hospitals and many facilities require Basic or Advanced Cardiac
Life Support classes that are available only through the AHA. Therefore, all the staff involved in
this decision have been exposed to the 2015 guidelines and might have an expectation that any
policy change is below the standard of care if they are not familiar with the evidence.
With any change that affects patient care, the patient and their family members are the
ultimate stakeholder. Because this is a specialty intervention after a specific event, the majority
of families will not be familiar with the intervention. However, aspects of the treatment plan
should always be discussed with the patient or designated decision maker and consent obtained
where applicable.
4. Implementation Plan
The change to maintenance of normothermia in place of TH will take place primarily in the
Emergency Department and the Intensive Care Unit. Although patients on in-patient floors
might experience cardiac arrest with resuscitation, the nurses on those floors would not be
implementing TH, nor would the physicians order it without an immediate transfer to Intensive
Care. In this facility, the Intensivist takes over care from the hospitalist upon transfer. The data
needed to make the change are the studies showing the ineffectiveness of TH. Additional data
can be presented regarding cost savings in training, personnel, and equipment. The stakeholders
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impacted by this change are the emergency and critical care providers implementing a post
resuscitation care plan. Critical care and emergency nurses are also impacted due to the practice
change. The policy change gives an opportunity to support evidence-based change in critical
care and inter-unit cooperation to support vulnerable patients. Furthermore, the change begins
the opportunity to develop clinical practice guidelines for Intensive Care Unit patients and
specifically for patients post resuscitation (Melnyk, Grinspun & Fineout-Overholt, 2015, p. 182).
Permission will be needed from the medical director of both units and the nursing director should
be notified. Allies in the organization can potentially be identified in the educators for both
departments as well as the education department. These allies will be selected to form a task
force for the implementation of this change. The task force of best practice champions (Melnyk,
Grinspun & Fineout-Overholt, 2015, p. 195) would help to disseminate information about the
change and support change on the unit. Potential barriers include the challenging of the status
quo and holdouts in the change process that want to see every possible intervention done to
maximize the chances of retained neurological function, though no proven benefit exists.
Training should be performed to enact the change. Each unit should have a brief update done
during routine staff meeting and an interdisciplinary meeting would ideally be scheduled to
discuss interventions best supported by the evidence in post-CA patients. No additional supplies
should be utilized. The unit educator for the critical care department and task force members
could perform audits on post-CA patients to determine which interventions are being utilized.
Maintaining normothermia post ROSC will result in cost savings to the organization. The period
of cooling, maintenance and rewarming require one on one nursing from a nurse trained on the
equipment. The change will decrease personnel costs as well as the additional in-service and
orientation hours needed to train individuals on the equipment. The existing equipment will not
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need to be replaced, a savings of roughly $25,000 per machine, plus the associated one-time use
items such as cooling pads and annual and periodic maintenance for the equipment
There are three phases of the implementation plan. First, educational meetings will be
scheduled to inform members of the organization of the change. During these meetings,
individuals can be identified to help the units process the change or self-select to be involved in
the task force. Then, the change will “go live” on a set day, giving the providers a chance to
receive the disseminated information of the change. Thirty days after the educational meetings
are scheduled and carried out would be the scheduled go live day. Routine evaluations would be
performed in the post-implementation phase to determine what orders are implemented post
resuscitation. Audits will be performed by the task force members. Additionally, to show the
benefit of the change, patients should be scored to determine level of neurological function post
ROSC and followed up to determine if alive at 90 days post event.

5. Timetable/Flowchart
Timeline of events over 90 days
Day 1-30
Informational meetings carried out in Critical Care areas
EBP champions identified (self or via selection)
Day 31
“Go live” day, change is implemented
Day 31-90+
Chart audits of successfully resuscitated patients performed
Follow up at 90 days post code for final neurological outcome scale
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6. Data Collection Methods
The evaluation will be retrospective and prospective. The retrospective data will look at
all the patients who have undergone therapeutic hypothermia in the last two years. Analysis will
be performed to determine if patient survived to hospital discharge, was diagnosed with a
hospital acquired infection and the neurological outcome (where able to be analyzed). The
neurological outcome will be the hardest to determine because there has been no standardized
way to rate the outcomes prior to this point. The physical and occupational therapy assessments
and physician notes will be used to determine where on the neurological outcome scale the
patient falls. The scale selected is the Glasgow Outcome Scale- extended (Hahn, Souza, Haak &
Heiney, 2019). It rates the patient with an easy to use scale from 1-Death to 8 Upper Good
Recovery. Good neurological outcome will be either a 7 or 8 on the scale. An infection will be
counted as hospital acquired per the current policy as a culture (blood, sputum or otherwise)
obtained more than 24 hours post admission that tests positive for bacteria and it is not explicitly
stated by the attending physician as contaminate (Longview Regional Medical Center, 2019).
The hospital currently records information on all codes by placing a procedural code for
CPR. This will also serve to flag the charts of all cardiac arrest patients for further review. The
patients who have been treated by therapeutic hypothermia can further be narrowed down due to
the use of a specific order set and by vital sign logging. Alternative methods of determining
where therapeutic hypothermia was used is auditing the use of certain charge codes generated by
labels on the equipment. This will provide actual comparison data. Code sheets will be obtained
from the House Supervisor who attends all codes and in conjunction with the ICU/ ER Charge
Nurse, fills a code sheet out. Evaluation after therapeutic hypothermia is initiated will include
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data on time until ROSC (in minutes), neurological status pre and post event, age and whether a
hospital acquired infection developed during hospitalization. The information on infections will
either be yes or no, as it will be clear from the date and time a culture was collected whether it
was 24 hours post arrival to the hospital. This will likely show a decrease in hospital acquired
infections in patients not treated with therapeutic hypothermia. Neurological outcome (pre) will
be subtracted from the outcome. This number is used to demonstrate differences in neurological
function after resuscitation. The neurological deficit, if any, will be compared to the therapeutic
hypothermia neurological deficit, calculated on the pre-intervention data obtained in the last two
years. All this data will be recorded in the spreadsheet to follow. This is a simple way of having
verifiable and reproducible data. Patients who expire during the hospitalization will not be
included. Though the Glasgow extended scale does account for death, it cannot account for the
families that elect to withdraw care.
The difference in pre and post neurological function will be compared via independent t tests
to determine if there is a statistically significant difference (Independent t-test for two samples,
n.d.). The significance is set at p=0.05. Additionally, median time to ROSC with interquartile
ranges will be set. The data set will be divided between patients with a favorable neurological
outcome and unfavorable outcome. This can be helpful in determining the success of future
resuscitation attempts after certain periods of time have elapsed. Simple percentages will be used
to determine how many patients in the therapeutic hypothermia and how many in the
normothermia group develop an infection.

7. Cost/Benefit Discussion
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With the use of normothermia as opposed to Therapeutic Hypothermia, there are few, if any
additional costs. Patients will be managed to keep their body temperature 36 to 38 degrees
Celsius (96.8 to 100.4 degrees Fahrenheit). This will be accomplished using acetaminophen for
the treatment of hyperthermia as well as cooling blankets, or warm blankets and Bair huggers for
hypothermic patients. All of these items are already present in Intensive Care Units, thus yielding
not additional cost. The cost of acetaminophen is negligible during an Intensive Care Unit stay.
Some of the data to evaluate the change will be qualitative to examine what orders are
being implemented in post cardiac arrest patients. Additional data will examine the actual
temperature control of patients. A neurological assessment tool shall be performed prior to
discharge and patients will be followed up with to determine a final disposition at 90 days post
event. Upon looking at both the materials and staffing spending, there should be decreases in
both categories owing to the elimination of the expenses to train personnel, repair and acquire
special machines for the purpose of TH.
If the change cannot be enacted at the original go live date, then the contacts can be used
to create a greater interdepartmental cooperation. This cooperation and the contacts in each
department can be utilized to implement other evidence-based change and work back up to the
elimination of therapeutic hypothermia and implementation of normothermia, or prevention of
hyperthermia in post cardiac arrest patients. Alternately, if resistance is met, encouraging the
aggressive treatment of fever can be a starting point and is supported by the evidence

8. Discussion of Results
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One way to evaluate if this plan is successful is to compare the two sets of data to look at the
neurological outcome and mortality. If we cannot show the benefits of normothermia, then the
physicians will continue to order hypothermia.
The primary way to determine if the plan was a success is to investigate the care on
patient’s post-ROSC to determine whether or not therapeutic hypothermia is being ordered or not
and by whom. If you have one provider who is holding out on the change, it may be possible to
revisit the issue once other providers have made the change and have data from the patients
involved. If a multitude of providers are not following the change, then the core efforts have
failed and the implementation of the change itself must be revisited.
As far as patient outcomes, there should be no change when maintaining normothermia is
utilized over therapeutic hypothermia. However, a decrease in pneumonia in the post-ROSC
population should be notable.

9.Conclusions/Recommendations
Evidence-based practice is a cornerstone of nursing practice; however, nothing that
happens in the nurse-patient interaction happens in a bubble. Because we are working with
human beings who have opinions, feelings and desires related to their health care, patient
preference must be accounted for. Patients can research different treatment options online and
might encounter data from an unreliable source or rely on old data when looking up different
treatments or medications. Not every article on the internet comes from a reliable source and not
every patient or family member will have the ability to discern which articles are superior and
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can hold up to scrutiny. Previous experience can often be counted as evidence (English Long,
Gallagher-Ford &Fineout-Overholt, 2010).
Additionally, as an intervention might be proved as unreliable, patients or their families
might still perceive it as the standard of care. This could be the case with therapeutic
hypothermia. As the American Heart Association still recommends targeted temperature
management post resuscitation for a shockable arrest, families who have experienced cardiac
arrest or with family members in health care could be aware of these guidelines (Scirica, Scirica
& Levine Cardiac Intensive Care Unit, 2013). Failure to communicate the up to date research
and rationale behind a decision could lead to families with the belief that not everything is being
done to save their loved one or with the perception that workers do not value their family
member’s life. Additionally, stakeholders in the organization might be more apt to follow the
American Heart Association, because it is a large organization and has brand recognition and
therefore perceived credibility.
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Appendix A

Synthesis Table

Time to ROSC
(min)

example

post intervention

Encounter # Age (years)
xxxxxxx
9001234
67 32 min

9006543

54 41 min

Survival to
Discharge
yes

no

Neuro Scale PRE
if available
7

8

Neuro Scale
Post

Infection TH

NT

2

yes

yes

no

1

n/a

no

yes
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Appendix B
Flowchart

• Meet with CNO, create policy
• Take to Policy Commitee- rewrite as
needed
Policy Approval • Approval by Corporate

Policy PreImplementation

Policy
Implemented

• Meeting with Medical Director, Critical
Care Directors to discuss change
• Informatics creates post-ROSC template

• Nursing educated in unit meetings and
via email with rationales
• Artic Sun machines moved to storage

• Changes reinforced in post
code debriefings
• Monitor charts for
normothermia compliance
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Appendix C

Instrument
Evaluation Tool
1. The teaching/learning resource(s) were adequate.
Not at all
Somewhat
Almost Completely
Completely
2. The content was relevant to the learning outcome.
Not at all
Somewhat
Almost Completely
Completely
3. The learning objectives were clearly stated.
Not at all
Somewhat
Almost Completely
Completely
Review the literature showing no benefit in therapeutic hypothermia
Not at all
Somewhat
Almost Completely
Completely
Describe the promotion of normothermia as an alternative treatment.
Not at all
Somewhat
Almost Completely
Completely
Describe the implementation and evaluation of the change from TH to normothermia.
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Not at all
Somewhat
Almost Completely
Completely
4. The length of the program was adequate.
Not at all
Somewhat
Almost Completely
Completely
5. The overall program was satisfactory.
Not at all
Somewhat
Almost Completely
Completely

